ketanserin has been researched along with Endotoxemia in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Walther, A | 2 |
Petri, E | 1 |
Peter, C | 2 |
Czabanka, M | 1 |
Martin, E | 2 |
Secchi, A | 1 |
Gebhard, MM | 1 |
Schmidt, H | 1 |
2 other studies available for ketanserin and Endotoxemia
Article | Year |
---|---|
Selective serotonin-receptor antagonism and microcirculatory alterations during experimental endotoxemia.
Topics: Animals; Blood Flow Velocity; Cell Communication; Endothelium, Vascular; Endotoxemia; Ketanserin; Le | 2007 |
Selective serotonin receptor antagonism and leukocyte-independent plasma extravasation during endotoxemia.
Topics: Animals; Binding Sites; Cinanserin; Endothelium, Vascular; Endotoxemia; Extravasation of Diagnostic | 2002 |